RFcaller

RFcaller detects somatic mutations in tumor-normal paired samples using a machine learning-based pipeline to identify substitutions and insertions/deletions from whole-genome and whole-exome sequencing.


Key Features:

  • Machine Learning Integration: RFcaller leverages machine learning algorithms to improve identification of somatic mutations from sequencing data.
  • Read-level Features: The pipeline uses read-level features extracted from tumor-normal paired samples to inform variant calling.
  • Efficiency and Low Computational Demand: RFcaller operates with minimal computing resources compared to traditional pipelines.
  • High Accuracy and Validation: It detects substitutions and insertions/deletions from whole-genome and whole-exome data with validation reported against deep sequencing and Sanger sequencing.
  • Detection of Missed Driver Mutations: RFcaller identifies mutations in driver genes that may be overlooked by other approaches.

Scientific Applications:

  • Cancer Genomics Research: RFcaller provides high-confidence somatic mutation calls to support characterization of cancer genomes and identification of driver alterations.
  • Clinical Practice Integration: Its precision in detecting substitutions and insertions/deletions from WGS/WES data supports applications where accurate somatic mutation detection is required for diagnosis or treatment planning.

Methodology:

RFcaller employs a machine learning-based pipeline that utilizes read-level features from tumor-normal paired samples.

Topics

Details

License:
MIT
Cost:
Free of charge
Tool Type:
command-line tool
Operating Systems:
Mac, Linux, Windows
Programming Languages:
Python, Shell
Added:
2/22/2024
Last Updated:
11/24/2024

Operations

Data Inputs & Outputs

Publications

Díaz-Navarro A, Bousquets-Muñoz P, Nadeu F, López-Tamargo S, Beà S, Campo E, Puente XS. RFcaller: a machine learning approach combined with read-level features to detect somatic mutations. NAR Genomics and Bioinformatics. 2022;5(2). doi:10.1093/nargab/lqad056. PMID:37260508. PMCID:PMC10227442.

PMID: 37260508
Funding: - Ministerio de Ciencia e Innovación: PID2020-117185RB-I00, SAF2017-87811-R - European Union: PI17/01061, PMP15/00007 - ‘La Caixa’ Foundation CLLEvolution: HR17-00221 - Ministerio de Economía y Competitividad: RTI2018-094274-B-I00 - Generalitat de Catalunya: 2017-SGR-1142, 2021-SGR-01293 - Department of Education of the Basque Government: PRE_2017_1_0100 - AACR-Amgen Fellowship in Clinical/Translational Cancer Research: 21-40-11-NADE - European Hematology Association: RG-202012-00245 - Lady Tata Memorial Trust: LADY_TATA_21_3223

Downloads